High levels of the DNA-binding activity of E2F in adult T-cell leukemia and human T-cell leukemia virus type I-infected cells: Possible enhancement of DNA-binding of E2F by the human T-cell leukemia virus I transactivating protein, Tax

European Journal of Haematology

Volumn 58, Issue 2, 1997, Pages 114-120

  Mori, Naoki ^a,b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

ATL; E2F; HTLV I Tax

Indexed keywords

TAX PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; T CELL LEUKEMIA; TRANSACTIVATION; VIRUS INFECTION;

EID: 0030894013     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb00934.x     Document Type: Article

References (61)

1. UCHIYAMA T, YODOI J, SAGAWA K, TAKATSUKI K, UCHINO H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977: 50: 481-492.
2. OSAME M, USUKU K, IZUMO S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986: 1: 1031-1032.
3. JACOBSON S, RAINE CS, MINGIOLI ES, MCFARLIN DE. Isolation of HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature 1988: 331: 540-543.
4. HOLLSBERG R HAFLER DA. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993: 328: 1173-1182.
5. SIEKEVITZ M, FEINBERG MB, HOLBROOK N, WONG-STALL F, GREENE WC. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type-I. Proc Natl Acad Sci USA 1987: 84: 5389-5393.
6. x protein and bovine papilloma virus encoded E2 protein. Nucleic Acids Res 1988: 16: 6547-6566.
7. 1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1988: 85: 8526-8530.
8. MORI N, SHIRAKAWA F, SAITO K, MURAKAMI S, ODA S, ETO S. Transactivation of the interleukin-1α gene promoter by human T-cell leukemia virus type I tax in T cells. Blood 1994: 84: 1688-1689.
9. MORI N, SHIRAKAWA F, SHIMIZU H, et al. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: evidence for the involvement of NF-κB. Blood 1994: 84: 2904-2911.
10. MORI N, MURAKAMI S, ODA S, PRAGER D, ETO S. Production of interleukin 8 in adult T-cell leukemia cells: possible transactivation of the interleukin 8 gene by human T-cell leukemia virus type I tax. Cancer Res 1995: 55: 3592-3597.
11. FUJII M, NIKI T, MORI T, et al. HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 1991: 6: 1023-1029.
12. AKAGI T, SHIMOTOHNO K. Proliferative response of Taxi-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J Virol 1993: 67: 1211-1217.
13. GRASSMANN R, BERCHTOLD S, RADANT I, et al. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol 1992: 66: 4570-4575.
14. FRANCHINI G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 1995: 86: 3619-3639.
15. FUJISAWA J, TOITA M, YOSHIMURA T, YOSHIDA M. The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation. J Virol 1991: 65: 4525-4528.
16. SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev 1992: 6: 2066-2076.
17. SUZUKI T, FUJISAWA J, TOITA M, YOSHIDA M. The trans-activator Tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc Natl Acad Sci USA 1993: 90: 610-614.
18. SUZUKI T, HIRAI H, FUJISAWA J, FUJITA T, YOSHIDA M. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-κB p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-κB site and CArG box. Oncogene 1993: 8: 2391-2397.
19. ZHAO L-J, GIAM C-Z. Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. Proc Natl Acad Sci USA 1991: 88: 11445-11449.
20. ZHAO L-J, GIAM C-Z. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sci USA 1992: 89: 7070-7074.
21. KOVESDI I, REICHEL R, NEVINS JR. Identification of a cellular transcription factor involved in ElA transactivation. Cell 1986: 45: 219-228.
22. NEVINS JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992: 258: 424-429.
23. HIEBERT SW, BLAKE M, AZIZKHAN J, NEVINS JR. Role of E2F transcription factor in E1A-mediated tram activation of cellular genes. J Virol 1991: 65: 3547-3552.
24. MUDRYJ M, HIEBERT SW, NEVINS JR. A role for the adenovirus inducible E2F transcription factor in a proliferation-dependent signal transduction pathway. EMBO J 1990: 7: 2179-2184.
25. CAO L, FAHA B, DEMBSKI M, TSAI L-H, HARLOW E, DYSON N. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 1992: 355: 176-179.
26. CHELLAPPAN SP, HIEBERT S, MUDRYJ M, HOROWITZ JM, NEVJNS JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991: 65: 1053-1061.
27. COBRINIK D, WHYTE P, PEEPER DS, JACKS T, WEINBERG RA. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev 1993: 7: 2392-2404.
28. LEES E, FAHA B, DULIC V, REED SI, HARLOW E. Cyclin E/ cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 1992: 6: 1874-1885.
29. SHIRODKAR S, EWEN M, DECAPRIO JA, MORGAN J, LIVINGSTON DM, CHITTENDEN T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 1992: 68: 157-166.
30. HIJMANS EM, VOORHOEVE PM, BEIJERSBERGEN RL, VAN'T VEER LJ, BERNARDS R. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol 1995: 15: 3082-3089.
31. LAM EW-F, LA THANGUE NB. DP and E2F proteins: coordinating transcription with cell cycle progression. Curr Opin Cell Biol 1994: 6: 859-866.
32. SARDET C, VIDAL M, COBRINIK D, et al. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 1995: 92: 2403-2407.
33. ZHANG Y, CHELLAPPAN SP. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 1995: 10: 2085-2093.
34. BANDARA LR, LAM EW-F, SORENSEN TS, ZAMANIAN M, GIRLING R, LA THANGUE NB. DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein. EMBO J 1994: 13: 3104-3114.
35. BEIJERSBERGEN RL, KERKHOVEN RM, ZHU L, CARLEE L, VOORHOEVE PM, BERNARDS R. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 1994: 8: 2680-2690.
36. GINSBERG D, VAIRO G, CHITTENDEN T, et al. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 1994: 8: 2665-2679.
37. HELIN K, WU C-L, FATTAEY AR, et al. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev 1993: 7: 1850-1861.
38. KREK W, LIVINGSTON DM, SHIRODKAR S. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 1993: 262: 1557-1560.
39. MUDRYJ M, HIEBERT SW, NEVINS JR. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J 1990: 9: 2179-2184.
40. LAM EW-F, WATSON RJ. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 1993: 12: 2705-2713.
41. SLANSKY JE, LI Y, KAELIN WG, FARNHAM PJ. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol 1993: 13: 1610-1618.
42. DOU Q-R ZHAO S, LEVIN AH, WANG, J, HELIN K, PARDEE AB. G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J Biol Chem 1994: 269: 1306-1313.
43. MUDRAK I, OGRIS E, ROTHENEDER H, WINTERSBERGER E. Coordinated trans activation of DNA synthesis- and precursor-producing enzymes by polyomavirus large T antigen through interaction with the retinoblastoma protein. Mol Cell Biol 1994: 14: 1886-1892.
44. SALA A, NICOLAIDES NC, ENGELHARD A, et al. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Cancer Res 1994: 54: 1402-1406.
45. HSIAO K-M, MCMAHON SL, FARNHAM PJ. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev 1994: 8: 1526-1537.
46. JOHNSON DG, OHTANI K, NEVINS JR. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 1994: 8: 1514-1525.
47. NEUMAN E, FLEMINGTON EK, SELLERS WR, KAELIN JR WG. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol 1994: 14: 6607-6615.
48. QIN X-Q, LIVINGSTON DM, KAELIN JR WG, ADAMS PD. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 1994: 91: 10918-10922.
49. SHAN B, LEE W-H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 1994: 14: 8166-8173.
50. KOWALIK TF, DEGREGORI J, SCHWARZ JK, NEVINS JR. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol 1995: 69: 2491-2500.
51. JOHNSON DG, SCHWARZ JK, CRESS WD, NEVINS JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993: 365: 349-352.
52. ARMSTRONG AP, FRANKLIN AA, UITTENBOGAARD MN, GIEBLER HA, NYBORG JK. Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors. Proc Natl Acad Sci USA 1993: 90: 7303-7307.
53. WAGNER S, GREEN MR. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 1993: 262: 395-399.
54. ANDERSON MG, DYNAN WS. Quantitative studies of the effect of HTLV-I Tax protein on CREB protein-DNA binding. Nucleic Acids Res 1994: 22: 3194-3201.
55. MORI N, PRAGER D. High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax. Cancer Res 1996: 56: 779-782.
56. MIYOSHI I, KUBONISHI I, YOSHIMOTO S, et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981: 294: 770-771.
57. GAZDAR AF, CARNEY DN, BUNN PA, et al. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 1980: 55: 409-417.
58. MIYOSHI I, KUBONISHI I, SUMIDA M, et al. A novel T-cell line derived from adult T-cell leukemia. Jpn J Cancer Res 1980: 71: 155-156.
59. TANAKA A, TAKAHASHI C, YAMAOKA S, NOSAKA T, MAKI M, HATANAKA M. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 1990: 87: 1071-1075.
60. FURUKAWA Y, OSAME M, KUBOTA R, TARA M, YOSHIDA M. Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 1995: 85: 1865-1870.
61. GROSSMAN WJ, KIMATA JT, WONG F-H, ZUTTER M, LEY TJ, RATNER L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1995: 92: 1057-1061.